Zobrazeno 1 - 10
of 1 088
pro vyhledávání: '"M Callaghan"'
Autor:
M Callaghan, K Ataga, L De Franceschi, C Minniti, N Balachandran, D Imbs, T Perretti, J Ramos, A Sostelly, P Bartolucci
Publikováno v:
HemaSphere, Vol 6, Pp 27-28 (2022)
Externí odkaz:
https://doaj.org/article/95890a90d1f2406aa6a30d693a8ec696
Autor:
P Bartolucci, K Ataga, M Callaghan, L De Franceschi, C Minniti, A Alexandrou, D Imbs, R Fox, H Patel, A Sostelly, J Schimmel
Publikováno v:
HemaSphere, Vol 6, Pp 27-27 (2022)
Externí odkaz:
https://doaj.org/article/125db8734c7e4efc9a69c7925f246d04
Autor:
Jean-Louis A. Parmasad, Konrad M. Ricke, Benjamin Nguyen, Morgan G. Stykel, Brodie Buchner-Duby, Amanda Bruce, Haley M. Geertsma, Eric Lian, Nathalie A. Lengacher, Steve M. Callaghan, Alvin Joselin, Julianna J. Tomlinson, Michael G. Schlossmacher, William L. Stanford, Jiyan Ma, Patrik Brundin, Scott D. Ryan, Maxime W. C. Rousseaux
Publikováno v:
Cell Death and Disease, Vol 15, Iss 4, Pp 1-13 (2024)
Abstract Parkinson’s disease (PD) is a debilitating neurodegenerative disease characterized by the loss of midbrain dopaminergic neurons (DaNs) and the abnormal accumulation of α-Synuclein (α-Syn) protein. Currently, no treatment can slow nor hal
Externí odkaz:
https://doaj.org/article/3314777d4067426182b748c43099f849
Autor:
Haley M. Geertsma, Zoe A. Fisk, Lillian Sauline, Alice Prigent, Kevin Kurgat, Steve M. Callaghan, aSCENT-PD Consortium, Michael X. Henderson, Maxime W. C. Rousseaux
Publikováno v:
npj Parkinson's Disease, Vol 10, Iss 1, Pp 1-14 (2024)
Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide and presents pathologically with Lewy pathology and dopaminergic neurodegeneration. Lewy pathology contains aggregated α-synuclein (αSyn), a protein e
Externí odkaz:
https://doaj.org/article/cd239cac18f9472889efe915a9b430df
Publikováno v:
Frontiers in Psychology, Vol 15 (2024)
Externí odkaz:
https://doaj.org/article/f5c2a920d89144e29ff34b7fcdf0c5ad
Autor:
Julio Rivera Vazquez, Edna Trujillo, Jonathan Williams, Fukang She, Fitsum Getahun, Melanie M. Callaghan, Joshua J. Coon, Daniel Amador-Noguez
Publikováno v:
Biotechnology for Biofuels and Bioproducts, Vol 17, Iss 1, Pp 1-23 (2024)
Abstract Background Recent engineering efforts have targeted the ethanologenic bacterium Zymomonas mobilis for isobutanol production. However, significant hurdles remain due this organism’s vulnerability to isobutanol toxicity, adversely affecting
Externí odkaz:
https://doaj.org/article/7c6f363b47c441778d8687b22729dc78
Autor:
Barbara Burkhardt, MD, Beate Rücker, MD, Alessia Callegari, MD, Martin Hersberger, PhD, Julia Geiger, MD, Fraser M. Callaghan, PhD, Christian Kellenberger, MD, Emanuela R. Valsangiacomo Büchel, MD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100182- (2024)
Externí odkaz:
https://doaj.org/article/86d5acec0ecb4eb5a2fc83455b6b86f2
Autor:
Odile Burdet, MSc, Barbara Burkhardt, MD, Kerstin Wustmann, MD, Fraser M. Callaghan, PhD, Emanuela R. Valsangiacomo Büchel, MD, Jean-Paul Vallée, MD, Judith Bouchardy, MD, Matthias Greutmann, MD, Markus Schwerzmann, MD, Harald Gabriel, MD, Dominik Stambach, MD, Daniel Tobler, MD, Juerg Schwitter, MD, PhD, Tobias Rutz, MD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100534- (2024)
Externí odkaz:
https://doaj.org/article/208a77e314254817b68627c1a9c91da9
Autor:
Odile Burdet, MSc, Barbara Burkhardt, MD, Kerstin Wustmann, MD, Fraser M. Callaghan, PhD, Emanuela R. Valsangiacomo Büchel, MD, Jean-Paul Vallée, MD, Judith Bouchardy, MD, Matthias Greutmann, MD, Markus Schwerzmann, MD, Harald Gabriel, MD, Dominik Stambach, MD, Daniel Tobler, MD, Juerg Schwitter, MD, PhD, Tobias Rutz, MD
Publikováno v:
Journal of Cardiovascular Magnetic Resonance, Vol 26, Iss , Pp 100533- (2024)
Externí odkaz:
https://doaj.org/article/90de0feef0b347bd9f29a74d2129688e
Autor:
Elena V Kuklina, Alexander C Ewing, Glen A Satten, William M Callaghan, David A Goodman, Cynthia D Ferre, Jean Y Ko, Lindsay S Womack, Romeo R Galang, Charlan D Kroelinger
Publikováno v:
PLoS ONE, Vol 18, Iss 11, p e0294140 (2023)
BackgroundSevere maternal morbidity (SMM) is broadly defined as an unexpected and potentially life-threatening event associated with labor and delivery. The Centers for Disease Control and Prevention (CDC) produced 21 different indicators based on In
Externí odkaz:
https://doaj.org/article/48e787ef70f84f9f84327d52e5b63278